Acetylation Targeting Chimera Enables Acetylation of the Tumor Suppressor p53

Md Kabir(Icahn School of Medicine at Mount Sinai), Jian Jin(Icahn School of Medicine at Mount Sinai)

Journal of the American Chemical Society

June 26, 2023

10.1021/jacs.3c04640

Cited by 53

Related Papers

A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases

|ACS Chemical Biology|2015|290

Discovery of Potent and Selective WDR5 Proteolysis Targeting Chimeras as Potential Therapeutics for Pancreatic Cancer

|Journal of Medicinal Chemistry|2023|50

Discovery of a novel, highly potent EZH2 PROTAC degrader for targeting non-canonical oncogenic functions of EZH2

|European Journal of Medicinal Chemistry|2024|36

Targeted Degradation of PRC1 Components, BMI1 and RING1B, via a Novel Protein Complex Degrader Strategy

|Advanced Science|2023|25

Dissecting and targeting noncanonical functions of EZH2 in multiple myeloma via an EZH2 degrader

|Oncogene|2023|25